Editor's Desk

Features Live, listen and learn

Live, listen and learn

Companies are realizing that they need to be more attuned to their audience

Opinion

Features Down... but not out

Down... but not out

Satisfaction levels among pharma-based respondents fell, but didn't exactly tank

Agency TEDMED 2014: Changing the Game & Curing the Sickness of Fear

TEDMED 2014: Changing the Game & Curing the Sickness of Fear

The great thing about TEDMED—the promise of the brand—is that it will inspire you to see the world differently. On this most important score, TEDMED succeeded in some spectacular ways.

Digital Why Pharma Should Stop Marketing Products and Start Marketing Services

Why Pharma Should Stop Marketing Products and Start Marketing Services

Today, we're all still trying to get people to buy our drugs and be a trusted health advisor, but these two goals seem to be working firmly against each other.

Education Pharma's role in cost control

Pharma's role in cost control

It may be time to adopt a model in which we help deliver healthcare

Features Think you own your brand? Think again

Think you own your brand? Think again

When you have a successful brand, you tamper with it at your peril

Features We've only just begun

We've only just begun

We cemented our credibility during the most difficult period for publishing

Features Going for the ultimate goal

Going for the ultimate goal

Since when was the US better at soccer than advertising?

As I See It As I See It: Patient Centricity

As I See It: Patient Centricity

A patient who is diagnosed earlier and receives the most efficacious treatment is the least expensive

Vantage Point Vantage Point: Payers—the "experts" in healthcare research

Vantage Point: Payers—the "experts" in healthcare research

Access to payers is about knowledge, about understanding what they do in their jobs

Features Bringing back the magic

Bringing back the magic

At MM&M's Leadership Exchange, the passion, candor, enthusiasm and respect were second-to-none

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.